|
Volumn 110, Issue 6, 2002, Pages 743-745
|
Cancer therapy and renal injury
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CASPASE 3;
CASPASE 8;
CISPLATIN;
DIMETHYLTHIOUREA;
INTERLEUKIN 10;
INTERLEUKIN 1BETA CONVERTING ENZYME;
PROTEIN INHIBITOR;
SCAVENGER;
SUPEROXIDE DISMUTASE;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTAGONIST;
UNCLASSIFIED DRUG;
ACUTE KIDNEY FAILURE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
APOPTOSIS;
CANCER;
CANCER THERAPY;
CELL DEATH;
CELL TYPE;
CONTROLLED STUDY;
CYTOKINE PRODUCTION;
CYTOKINE RELEASE;
DOSE RESPONSE;
DRUG EFFECT;
ENZYME ACTIVATION;
ENZYME INHIBITION;
KIDNEY INJURY;
LEUKOCYTE ACTIVATION;
LIVER TOXICITY;
MONOCYTE;
MOUSE;
NATURAL KILLER CELL;
NEUTROPHIL;
NONHUMAN;
NOTE;
PATHOGENESIS;
PRIORITY JOURNAL;
T LYMPHOCYTE;
|
EID: 0036738495
PISSN: 00219738
EISSN: None
Source Type: Journal
DOI: 10.1172/JCI0216568 Document Type: Note |
Times cited : (105)
|
References (21)
|